메뉴 건너뛰기
Retina
Volumn 26, Issue 3, 2006, Pages 352-354
Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment
Author keywords

Bevacizumab; Diabetic retinopathy; Neovascularization; Rubeosis
Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;
EID: 33646447443     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200603000-00016     Document Type: Article
Times cited : (304)
References (6)
  • 1
    • 4143136640 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: Basic science in clinical progress
    • Ferrara N. Vascular endothelial growth factor: basic science in clinical progress. Endocrinol Rev 2004;25:581-611.
    • (2004) Endocrinol Rev , vol.25 , pp. 581-611
    • Ferrara, N.1
  • 2
    • 23044505200 scopus 로고    scopus 로고
    • Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
    • Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335.
    • (2005) Ophthalmic Surg Lasers Imaging , vol.36 , pp. 331-335
    • Rosenfeld, P.J.1    Moshfeghi, A.A.2    Puliafito, C.A.3
  • 3
    • 33644502828 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration
    • Avery RL, Pieramici D, Rabena M, et al. Intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372.
    • (2006) Ophthalmology , vol.113 , pp. 363-372
    • Avery, R.L.1    Pieramici, D.2    Rabena, M.3
  • 4
    • 0030067257 scopus 로고    scopus 로고
    • Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
    • Adamis AP, Shirma DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996;114:66-71.
    • (1996) Arch Ophthalmol , vol.114 , pp. 66-71
    • Adamis, A.P.1    Shirma, D.T.2    Tolentino, M.J.3
  • 5
    • 29644444716 scopus 로고    scopus 로고
    • Changes in retinal neovascularization following pegaptanib (Macugen) therapy in diabetic individuals
    • Macugen Diabetic Retinopathy Study Group. Changes in retinal neovascularization following pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006;113:23-28.
    • (2006) Ophthalmology , vol.113 , pp. 23-28
  • 6
    • 0032864292 scopus 로고    scopus 로고
    • Comparisons of the intraocular tissue distribution pharmacokinetics and safety of 125 I-labeled Fab antibodies in rhesus monkeys following intravitreal administration
    • Mordenti J, Cuthbertson RA, Ferrara N, et al. Comparisons of the intraocular tissue distribution pharmacokinetics and safety of 125 I-labeled Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol 1999;27:536-544.
    • (1999) Toxicol Pathol , vol.27 , pp. 536-544
    • Mordenti, J.1    Cuthbertson, R.A.2    Ferrara, N.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.